| Original language | English |
|---|---|
| Pages (from-to) | 1844-1846 |
| Number of pages | 3 |
| Journal | Journal of Clinical Oncology |
| Volume | 43 |
| Issue number | 15 |
| DOIs | |
| State | Published - May 20 2025 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Reply to: Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas
- Christopher L. Moertel
- , Angela C. Hirbe
- , Laura J. Klesse
- , P. Leia Nghiemphu
- , Dusica Babovic-Vuksanovic
- , Timothy R. Gershon
- Section of Medical Oncology
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Cancer Biology
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- Institute of Clinical and Translational Sciences (ICTS)
- Brain Tumor Center
- Bursky Center for Human Immunology and Immunotherapy
- Neurofibromatosis (NF) Center
- Siteman Cancer Center
Research output: Contribution to journal › Letter › peer-review